Literature DB >> 8287592

Failure in IgA secretion by surface IgA-positive B cells in common variable immunodeficiency (CVID).

L J Scott1, A Bryant, A D Webster, J Farrant.   

Abstract

CVID is an acquired disease with low serum immunoglobulins. Patients are classified into three groups on the ability of their B cells to secrete IgM and IgG in vitro in response to IL-2. We have now extended this patient classification to include IgA secretion and to assess whether the patients have IgA+ B cells in the circulation. B cells from almost all of the CVID patients studied were unable to secrete any IgA in vitro, with or without IL-2, although all B cells tested from normal donors showed some spontaneous IgA secretion. Thus, the defect with IgA secretion is more profound than with the secretion of IgM or IgG. Despite this failure to secrete IgA, using flow cytometry techniques all CVID patients tested were found to have IgA+ cells (expressed as a percentage of B cells) within the normal range. This suggests that CVID may involve a defect in the secretion of immunoglobulin isotypes rather than a defect in isotype switching.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8287592      PMCID: PMC1534626          DOI: 10.1111/j.1365-2249.1994.tb06007.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  9 in total

Review 1.  Lymphocyte surface phenotype in common variable immunodeficiency.

Authors:  G P Spickett; N Matamoros; J Farrant
Journal:  Dis Markers       Date:  1992 Mar-Apr       Impact factor: 3.434

Review 2.  Cellular abnormalities in common variable immunodeficiency.

Authors:  G P Spickett; A D Webster; J Farrant
Journal:  Immunodefic Rev       Date:  1990

3.  B cell function in acquired "common-variable" hypogammaglobulinemia: proliferative responses to lymphokines.

Authors:  J Farrant; A Bryant; F Almandoz; G Spickett; S W Evans; A D Webster
Journal:  Clin Immunol Immunopathol       Date:  1989-05

4.  Immunoglobulins on the surface of lymphocytes in fifty patients with primary immunodeficiency diseases.

Authors:  J L Preud'Homme; C Griscelli; M Seligmann
Journal:  Clin Immunol Immunopathol       Date:  1973-01

Review 5.  B and T cell markers in human proliferative blood diseases and primary immunodeficiencies, with special reference to membrane bound immunoglobulins.

Authors:  M Seligmann; J L Preud'Homme; J C Brouet
Journal:  Transplant Rev       Date:  1973

6.  Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interleukin-2.

Authors:  A Bryant; N C Calver; E Toubi; A D Webster; J Farrant
Journal:  Clin Immunol Immunopathol       Date:  1990-08

7.  T and B cell defects in common variable immunodeficiency.

Authors:  J Farrant
Journal:  Immunol Invest       Date:  1991-04       Impact factor: 3.657

8.  Phenotypically immature IgG-bearing B cells in patients with hypogammaglobulinemia.

Authors:  M Fiorilli; M Crescenzi; M Carbonari; L Tedesco; G Russo; C Gaetano; F Aiuti
Journal:  J Clin Immunol       Date:  1986-01       Impact factor: 8.317

9.  Functional 'immaturity' of isolated B cells from patients with hypogammaglobulinaemia.

Authors:  G C De Gast; S R Wilkins; A D Webster; A Rickinson; T A Platts-Mills
Journal:  Clin Exp Immunol       Date:  1980-12       Impact factor: 4.330

  9 in total
  3 in total

Review 1.  Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID).

Authors:  L Hammarström; I Vorechovsky; D Webster
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

Review 2.  Genetics of IgA deficiency and common variable immunodeficiency.

Authors:  H W Schroeder
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

3.  Ill-defined germinal centers and severely reduced plasma cells are histological hallmarks of lymphadenopathy in patients with common variable immunodeficiency.

Authors:  Susanne Unger; Maximilian Seidl; Annette Schmitt-Graeff; Joachim Böhm; Klaudia Schrenk; Claudia Wehr; Sigune Goldacker; Ruth Dräger; Barbara C Gärtner; Paul Fisch; Martin Werner; Klaus Warnatz
Journal:  J Clin Immunol       Date:  2014-05-02       Impact factor: 8.317

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.